Literature DB >> 1627629

Emerging role of lipids of Candida albicans, a pathogenic dimorphic yeast.

P Mishra1, J Bolard, R Prasad.   

Abstract

It is clear that C. albicans lipids have gained tremendous importance in recent years. In addition to being a barrier for entrance of various metabolites, it also provides the site of action for the synthesis of enzyme(s) involved in cell wall morphogenesis and antifungal action. While alterations in lipid composition during a yeast to mycelia transition have been observed, in most of the studies, lipid fluctuations reported could have been due to various environmental factors involved in the induction of morphogenesis [4,5]. A clear understanding of lipid biosynthesis and metabolic blocks due to antifungal action is likely to shed further light on selective interactions of antifungals. Despite the multifacet role of lipids in various functions of this pathogenic yeast, their exact involvement is poorly understood. The situation is little better with regard to ergosterol and its metabolism. Ergosterol is, indeed, important for anti-candidal activity and appears to be involved in the morphogenesis of C. albicans. The fluctuation in phospholipid composition have led to altered properties of plasma membrane namely, membrane fluidity, transport activities and drug sensitivity, which suggest that-a critical level of individual phospholipid is important for proper functioning of the plasma membrane. What the exact role is of individual phospholipid is far from clear. Many unanswered questions relating to the role of PI and sphingomyelin in signal transduction, involvement of phospholipases in the maintenance of phospholipid composition, and role of lipid transfer proteins in assembly and asymmetry of lipids are some aspects which merit further work.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1627629     DOI: 10.1016/0005-2760(92)90194-z

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Sterol and fatty acid composition of Candida lusitaniae clinical isolates.

Authors:  F Peyron; A Favel; R Calaf; A Michel-Nguyen; R Bonaly; J Coulon
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

2.  Action of chlorhexidine digluconate against yeast and filamentous forms in an early-stage Candida albicans biofilm.

Authors:  Peter A Suci; Bonnie J Tyler
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

3.  Nimesulide inhibits pathogenic fungi: PGE2-dependent mechanisms.

Authors:  Rafaelle Fonseca de Matos; Lúcia Carla Vasconcelos Mendonça; Kaira Geiliane da Silva Souza; Adriana Aparecida Durães Fonseca; Elaine Mirla Souza Costa; Marcus Vinicius Dias de Lima; José Maria Dos Santos Vieira; Mioni Thielli Figueiredo Magalhães de Brito; Marta Chagas Monteiro
Journal:  Folia Microbiol (Praha)       Date:  2016-11-19       Impact factor: 2.099

4.  Induction of an extracellular esterase from Candida albicans and some of its properties.

Authors:  R Tsuboi; H Komatsuzaki; H Ogawa
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

5.  In vitro low-level resistance to azoles in Candida albicans is associated with changes in membrane lipid fluidity and asymmetry.

Authors:  Avmeet Kohli; Kasturi Mukhopadhyay; Ashok Rattan; Rajendra Prasad
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

6.  Modes of action of the new arylguanidine abafungin beyond interference with ergosterol biosynthesis and in vitro activity against medically important fungi.

Authors:  C Borelli; M Schaller; M Niewerth; K Nocker; B Baasner; D Berg; R Tiemann; K Tietjen; B Fugmann; S Lang-Fugmann; H C Korting
Journal:  Chemotherapy       Date:  2008-06-30       Impact factor: 2.544

7.  Chemical genetic profiling and characterization of small-molecule compounds that affect the biosynthesis of unsaturated fatty acids in Candida albicans.

Authors:  Deming Xu; Susan Sillaots; John Davison; Wenqi Hu; Bo Jiang; Sarah Kauffman; Nick Martel; Pam Ocampo; Chanseok Oh; Steve Trosok; Karynn Veillette; Hao Wang; Minghui Yang; Li Zhang; Jeffrey Becker; Charles E Martin; Terry Roemer
Journal:  J Biol Chem       Date:  2009-06-01       Impact factor: 5.157

8.  cAMP regulates vegetative growth and cell cycle in Candida albicans.

Authors:  Ajay Singh; Sadhna Sharma; Gopal K Khuller
Journal:  Mol Cell Biochem       Date:  2007-06-08       Impact factor: 3.396

Review 9.  PS, It's Complicated: The Roles of Phosphatidylserine and Phosphatidylethanolamine in the Pathogenesis of Candida albicans and Other Microbial Pathogens.

Authors:  Chelsi D Cassilly; Todd B Reynolds
Journal:  J Fungi (Basel)       Date:  2018-02-20

Review 10.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.